Biosynex SA
EPA:ALBIO.PA
2.76 (EUR) • At close November 8, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Biosynex SA |
Symbool | ALBIO.PA |
Munteenheid | EUR |
Prijs | 2.76 |
Beurswaarde | 29,700,084 |
Dividendpercentage | 0% |
52-weken bereik | 2.66 - 8.97 |
Industrie | Diagnostics & Research |
Sector | Healthcare |
CEO | Mr. Larry Abensur |
Website | https://www.biosynex.com |
An error occurred while fetching data.
Over Biosynex SA
Biosynex SA designs, manufactures, and distributes rapid diagnostic tests in France and internationally. The company offers a range of rapid diagnostic tests, immunoblots, molecular biology, and point of care products for screening, diagnosis, and prevention in the areas of bacteriology, parasitology, mycology, virology, biochemistry and oncology, and women's health, as
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (EUR)
Cijfers zijn in miljoenen (EUR)